DekaBank Deutsche Girozentrale boosted its stake in CME Group Inc (NASDAQ:CME) by 68.7% in the second quarter, HoldingsChannel reports. The institutional investor owned 479,058 shares of the financial services provider’s stock after buying an additional 195,144 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in CME Group were worth $93,092,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Truvestments Capital LLC bought a new position in shares of CME Group during the 1st quarter worth $32,000. Close Asset Management Ltd bought a new position in shares of CME Group during the 1st quarter worth $34,000. Advantage Investment Management LLC grew its stake in shares of CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after acquiring an additional 100 shares during the period. Westside Investment Management Inc. bought a new position in shares of CME Group during the 2nd quarter worth $38,000. Finally, Permanens Capital L.P. bought a new position in shares of CME Group during the 1st quarter worth $41,000. 84.44% of the stock is owned by institutional investors and hedge funds.
Shares of CME opened at $213.30 on Wednesday. The company has a market cap of $75.44 billion, a P/E ratio of 31.28, a PEG ratio of 4.82 and a beta of 0.23. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. The firm’s 50-day simple moving average is $203.45. CME Group Inc has a 12-month low of $161.05 and a 12-month high of $216.73.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.41%. CME Group’s dividend payout ratio is 43.99%.
Several research analysts have recently weighed in on CME shares. Barclays increased their price target on CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a research note on Thursday, May 23rd. Citigroup set a $202.00 price target on CME Group and gave the stock a “buy” rating in a research note on Thursday, May 2nd. Deutsche Bank increased their price target on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Rosenblatt Securities downgraded CME Group from a “neutral” rating to a “sell” rating in a research note on Thursday, April 18th. Finally, ValuEngine upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $194.00.
In related news, insider Kevin Kometer sold 16,140 shares of the firm’s stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $201.19, for a total transaction of $3,247,206.60. Following the transaction, the insider now directly owns 72,122 shares of the company’s stock, valued at approximately $14,510,225.18. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the transaction, the chief executive officer now directly owns 79,057 shares in the company, valued at $15,823,258.55. The disclosure for this sale can be found here. Over the last three months, insiders have sold 82,363 shares of company stock worth $16,429,225. 1.20% of the stock is currently owned by insiders.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
See Also: How to Invest in Marijuana Stocks
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.